Search Results 421-430 of 15988 for pharmacogenetics
Dr. Halena Gazelka 00:37. Welcome, everyone to Mayo Clinic Q&A. I'm your host, Dr. Halena Gazelka. Mayo Clinic. Biopharma Diagnostics collaborates with ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The Somatic Mutations in Development and Aging Lab of Alexej Abyzov, Ph.D., at Mayo Clinic studies the effects of DNA changes that happen during a person's ...
The purpose of this study is to evaluate circulating tumor DNA as a potential biomarker for pre-surgery treatment response in patients who have esophageal ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma.
Zhu, Jane M.D., Ph.D. zhu.shizhen@mayo.edu; Associate Professor of Biochemistry and Molecular Biology; Publications. More about research at Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.